Anavex Life Sciences Corp (AVXL)

[allthatglitters]

Spot on, Fireman. If 2-73 is approved doctors will be prescribing it for ALL their AD patients. Moreover, just because it works (if it works) best for a particular segment of people doesn't mean it won't have a positive, albeit lesser, effect on other patients.

Another point I and others have made and it bears repeating: If 2-73 gets ANY indication, it will be prescribed off-label for other diseases. With AD and PDD we're dealing with a desperate patient population for whom present SOC offers little to nothing. Anything that offers the slightest hint of a whisper of hope, especially with a good safety profile, will be taken with urgent enthusiasm by patients and eagerly prescribed by doctors. That's the reason (beyond helping the sick) that an indication for Retts would be so important. Demand will heat up, but AVXL is not equipped presently for manufacture and distribution. Our investment world will become very interesting, very quickly.